Molecular Imaging: Page 43

AI may help diagnose cardiac amyloidosis on whole-body scintigraphy

By Will Morton

An artificial intelligence (AI) model trained on whole-body scintigraphy images may be able to identify patients at risk of cardiac amyloidosis, according to a study published April 12 in JACC: Cardiovascular Imaging.

April 16, 2023

PET/MRI cuts breast cancer scan times in half

By Will Morton

PET/MRI breast cancer imaging time can be cut in half without losing key diagnostic information -- a finding that could increase the use of the modality for this indication and streamline radiology department throughput, researchers have reported.

April 16, 2023

Ultrasound noninferior to scintigraphy in surgical thyroid imaging

By Amerigo Allegretto

Ultrasound may be a viable alternative to scintigraphy for pre-surgical imaging of patients with primary hyperparathyroidism, even without the addition of contrast media, suggest findings published April 13 in JAMA Otolaryngology.

April 13, 2023

PET tracer for prostate cancer performs well in phase III trial

By Will Morton

PET/CT imaging with F-18 PSMA-1007 detects significantly more prostate cancer than imaging using the standard F-18 fluorocholine radiotracer, according to clinical results published in the April issue of the Journal of Nuclear Medicine.

April 13, 2023

AuntMinnie.com Molecular Imaging Insider

By Will Morton

April 12, 2023

FDA clears Fusion's targeted alpha therapy

By AuntMinnie.com staff writers

Fusion Pharmaceuticals has secured clearance from the U.S. Food and Drug Administration (FDA) for its radiopharmaceuticals actinium-225-FPI-2068 and corresponding imaging analog Indium-111-FPI-2107.

April 12, 2023

ImaginAB licenses immuno-PET tracer to Leucid

By AuntMinnie.com staff writers

Immuno-PET developer ImaginAB has licensed its zirconium-89 crefmirlimab berdoxam radiotracer to biotech company Leucid for use in studies of solid tumors.

April 11, 2023

China authorizes Qi Kang Medical Technology to open new facility

By AuntMinnie.com staff writers

The Department of Ecology and Environment of Jiangsu Province in China has authorized Eckert & Ziegler subsidiary Qi Kang Medical Technology to construct a radioisotope production facility in Jintan.

April 11, 2023

PET/CT bests bone scintigraphy for detecting invasive breast cancer

By Will Morton

PET/CT imaging surpasses bone scintigraphy for detecting bone metastases in women with invasive breast cancer and should be the technique of choice to stage these patients, according to a team of investigators from Portugal.

April 11, 2023

MICI Q4: Radiology admins confident in radiology volume growth

By Kate Madden Yee

Radiology administrators have very high confidence that diagnostic and interventional radiology exam volumes will grow in 2023, according to fourth-quarter 2022 numbers from the Medical Imaging Confidence Index (MICI).

April 9, 2023

PET superior to CT in women with metastatic breast cancer

By Will Morton

F-18 FDG-PET/CT imaging appears to be a better predictor of survival than contrast-enhanced CT for monitoring patients with metastatic breast cancer, according to a study published April 5 in Scientific Reports.

April 9, 2023

NIH highlights PET imaging in study of rare bone disease

By Will Morton

The U.S. National Institutes of Health (NIH) has highlighted a study featuring PET imaging of patients treated with denosumab, a new drug for a rare bone disease called fibrous dysplasia.

April 9, 2023

Previous Page

Page 43 of 612

Next Page